Literature DB >> 20621045

Reprogramming of human peripheral blood cells to induced pluripotent stem cells.

Judith Staerk1, Meelad M Dawlaty, Qing Gao, Dorothea Maetzel, Jacob Hanna, Cesar A Sommer, Gustavo Mostoslavsky, Rudolf Jaenisch.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20621045      PMCID： PMC2917234          DOI： 10.1016/j.stem.2010.06.002

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


× No keyword cloud information.
  30 in total

1.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

2.  Generation of induced pluripotent stem cells from human blood.

Authors:  Yuin-Han Loh; Suneet Agarwal; In-Hyun Park; Achia Urbach; Hongguang Huo; Garrett C Heffner; Kitai Kim; Justine D Miller; Kitwa Ng; George Q Daley
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

3.  Generation of human induced pluripotent stem cells from dermal fibroblasts.

Authors:  W E Lowry; L Richter; R Yachechko; A D Pyle; J Tchieu; R Sridharan; A T Clark; K Plath
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-15       Impact factor: 11.205

4.  A drug-inducible system for direct reprogramming of human somatic cells to pluripotency.

Authors:  Dirk Hockemeyer; Frank Soldner; Elizabeth G Cook; Qing Gao; Maisam Mitalipova; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

5.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

6.  Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.

Authors:  Jacob Hanna; Styliani Markoulaki; Patrick Schorderet; Bryce W Carey; Caroline Beard; Marius Wernig; Menno P Creyghton; Eveline J Steine; John P Cassady; Ruth Foreman; Christopher J Lengner; Jessica A Dausman; Rudolf Jaenisch
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

7.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

8.  Human induced pluripotent stem cells free of vector and transgene sequences.

Authors:  Junying Yu; Kejin Hu; Kim Smuga-Otto; Shulan Tian; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

9.  Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.

Authors:  Tobias Brambrink; Ruth Foreman; G Grant Welstead; Christopher J Lengner; Marius Wernig; Heikyung Suh; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2008-02-07       Impact factor: 24.633

10.  Disease-specific induced pluripotent stem cells.

Authors:  In-Hyun Park; Natasha Arora; Hongguang Huo; Nimet Maherali; Tim Ahfeldt; Akiko Shimamura; M William Lensch; Chad Cowan; Konrad Hochedlinger; George Q Daley
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582
View more
  185 in total

Review 1.  Stem cells as therapeutic vehicles for the treatment of high-grade gliomas.

Authors:  Emanuela Binello; Isabelle M Germano
Journal:  Neuro Oncol       Date:  2011-12-13       Impact factor: 12.300

2.  Generation of induced pluripotent stem cells from urine.

Authors:  Ting Zhou; Christina Benda; Sarah Duzinger; Yinghua Huang; Xingyan Li; Yanhua Li; Xiangpeng Guo; Guokun Cao; Shen Chen; Lili Hao; Yau-Chi Chan; Kwong-Man Ng; Jenny Cy Ho; Matthias Wieser; Jiayan Wu; Heinz Redl; Hung-Fat Tse; Johannes Grillari; Regina Grillari-Voglauer; Duanqing Pei; Miguel A Esteban
Journal:  J Am Soc Nephrol       Date:  2011-06-02       Impact factor: 10.121

3.  Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells.

Authors:  Brooke A DeRosa; Jessica M Van Baaren; Gaurav K Dubey; Joycelyn M Lee; Michael L Cuccaro; Jeffery M Vance; Margaret A Pericak-Vance; Derek M Dykxhoorn
Journal:  Neurosci Lett       Date:  2012-03-07       Impact factor: 3.046

Review 4.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

Review 5.  Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues.

Authors:  Jacob H Hanna; Krishanu Saha; Rudolf Jaenisch
Journal:  Cell       Date:  2010-11-12       Impact factor: 41.582

Review 6.  Present and future challenges of induced pluripotent stem cells.

Authors:  Mari Ohnuki; Kazutoshi Takahashi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

7.  Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.

Authors:  C Bueno; J L Sardina; B Di Stefano; D Romero-Moya; A Muñoz-López; L Ariza; M C Chillón; A Balanzategui; J Castaño; A Herreros; M F Fraga; A Fernández; I Granada; O Quintana-Bustamante; J C Segovia; K Nishimura; M Ohtaka; M Nakanishi; T Graf; P Menendez
Journal:  Leukemia       Date:  2015-10-26       Impact factor: 11.528

8.  Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds.

Authors:  Junqing Ye; Jian Ge; Xu Zhang; Lin Cheng; Zhengyuan Zhang; Shan He; Yuping Wang; Hua Lin; Weifeng Yang; Junfang Liu; Yang Zhao; Hongkui Deng
Journal:  Cell Res       Date:  2015-12-25       Impact factor: 25.617

9.  Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies.

Authors:  Itai M Pessach; Jose Ordovas-Montanes; Shen-Ying Zhang; Jean-Laurent Casanova; Silvia Giliani; Andrew R Gennery; Waleed Al-Herz; Philip D Manos; Thorsten M Schlaeger; In-Hyun Park; Francesca Rucci; Suneet Agarwal; Gustavo Mostoslavsky; George Q Daley; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2010-12-24       Impact factor: 10.793

10.  Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia.

Authors:  I-Ping Chen; Keiichi Fukuda; Noemi Fusaki; Akihiro Iida; Mamoru Hasegawa; Alexander Lichtler; Ernst J Reichenberger
Journal:  Cell Reprogram       Date:  2013-11-12       Impact factor: 1.987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.